EUVIMEDEUVIMED entdecken
Validierungsstudie

A rapid point-of-care test for the diagnosis of factor VIII inhibitors in hemophilia A patients

Shruti Kharat, Fiza Jivani, Kranti Patil, Gurpreet Kaur Saini, Anam Dhawlarker, Juili Bharankar, Shrimati Shetty

Journal of Thrombosis and Haemostasis · 2026-08 · 24 (8) · 2766-2778

DOI: 10.1016/j.jtha.2026.04.014 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-08. Verfasst von Shruti Kharat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, K.J. Somaiya Hospital & Research Center, Somaiya Ayurvihar, Sion East, Mumbai, India. Hauptthemen laut MEDLINE: Hemophilia A, Factor VIII, Point-of-Care Testing, Antibodies, Neutralizing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Department of Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The development of neutralizing antibodies or inhibitors against exogenous factor (F)VIII represents a major adverse event in hemophilia A treatment. The conventional assay for the diagnosis of FVIII inhibitors is the Nijmegen-modified Bethesda assay. This test is time-consuming, resource-intensive, and cost-prohibitive. The test lacks sensitivity and shows wide variation across quality surveys. OBJECTIVES: To develop a rapid, cost-effective, functionally relevant, sensitive, and specific test for FVIII inhibitors. METHODS: We developed and validated a cost-effective, accurate, and equipment-free point-of-care (POC) test for FVIII inhibitors in a paper-strip format using full-length recombinant FVIII and gold nanoparticle-labeled antibodies. RESULTS: The diagnostic sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the FVIII inhibitor POC test were 0.93, 0.99, 0.94, 0.99, and 0.98, respectively, compared with the Nijmegen-modified Bethesda assay. The test was rapid (10 minutes), cost-effective (USD ≈$1-$1.5), equipment-free (naked-eye test), and required only a small volume (50 μL) of citrated whole blood or citrated plasma. The POC test was unaffected by nonneutralizing antibodies, residual FVIII, emicizumab, lupus anticoagulants, or heparin. CONCLUSION: The POC test shows promise as a valuable screening tool in resource-limited settings for timely diagnosis of FVIII inhibitors and can be applied even at the lowest tier of the health care system, where sophisticated equipment or technical expertise may not be available. With a turnaround time of 10 minutes, this POC test will be highly useful for timely clinical decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AFactor VIIIPoint-of-Care TestingAntibodies, NeutralizingPoint-of-Care SystemsHumansPredictive Value of TestsTime FactorsCost-Benefit AnalysisRapid Diagnostic TestsReproducibility of ResultsMetal NanoparticlesGoldCost-Effectiveness AnalysisRecombinant Proteins

Stichwörter der Autor:innen

factor VIII inhibitorshemophilia Aneutralizing antibodiespoint-of-care testrapid diagnostic test

Substanzen

Factor VIIIAntibodies, NeutralizingF8 protein, humanGoldRecombinant Proteins

Autor:innen und Institutionen

  • Department of Haematology, K.J. Somaiya Hospital & Research Center, Somaiya Ayurvihar, Sion East, Mumbai, India.
  • Department of Haematology, K.J. Somaiya Hospital & Research Center, Somaiya Ayurvihar, Sion East, Mumbai, India. Electronic address: shrimati@somaiya.edu.

Förderung

  • Department of Biotechnology

Zitieren

APA

Kharat, S., Jivani, F., Patil, K., Saini, G. K., Dhawlarker, A., Bharankar, J., & Shetty, S. (2026). A rapid point-of-care test for the diagnosis of factor VIII inhibitors in hemophilia A patients. Journal of Thrombosis and Haemostasis, 24(8), 2766-2778. https://doi.org/10.1016/j.jtha.2026.04.014

Vancouver

Kharat S, Jivani F, Patil K, Saini GK, Dhawlarker A, Bharankar J, et al. A rapid point-of-care test for the diagnosis of factor VIII inhibitors in hemophilia A patients. Journal of Thrombosis and Haemostasis. 2026;24(8):2766-2778. doi:10.1016/j.jtha.2026.04.014

BibTeX
@article{Kharat2026,
  author = {Kharat, Shruti and Jivani, Fiza and Patil, Kranti and Saini, Gurpreet Kaur and Dhawlarker, Anam and Bharankar, Juili and Shetty, Shrimati},
  title = {A rapid point-of-care test for the diagnosis of factor VIII inhibitors in hemophilia A patients},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {8},
  pages = {2766--2778},
  doi = {10.1016/j.jtha.2026.04.014}
}
Kostenlos starten →